Four Oaks Partners

Four Oaks Partners is a boutique transaction advisory firm focused on the life sciences industry rather than a therapeutic product developer. The firm advises small and mid-sized biotechnology, medical device, life sciences tools, and related healthcare companies on strategic transactions, including business development, in-licensing and out-licensing, mergers and acquisitions, and broader strategic advisory work. It appears to have been founded in 2012 as a successor or continuation of the earlier life sciences advisory firm P2 Partners. The team has been described as bringing experience from biotechnology, medical devices, life sciences tools and services, venture capital, investment banking, and bench science. Based on available information, Four Oaks Partners does not appear to operate a proprietary drug pipeline.